Home / News
News
Yuhan to invest 14% of its sales in R&D this year for “Lazertinib’s Phase-3 trial & Global Open Innovation
In 2020, Yuhan Corporation is going to invest the largest amount in history for its R&D program to speed up the development of Lazertinib (YH25448)
July 30, 2020
No Comments
Yuhan USA’s 2019 Recap
With 2020 just around the corner, let’s take a look back at our 2019!It has been a wonderful year for us here at Yuhan USA
July 30, 2020
No Comments